Description
TB-500 is a synthetic peptide analog of thymosin beta-4 (Tβ4) designed for laboratory research. In experimental models, it has been studied for its interaction with actin-binding proteins involved in cellular migration and structural organization. Research observations indicate affinity for G-actin, with associated effects on cytoskeletal dynamics and molecular signaling pathways under controlled conditions. This peptide is also characterized in laboratory settings by proteolytic degradation and renal clearance mechanisms.
Drago Pharma Properties
| Chemical Formula | C212H350N56O78S |
| Synonyms | UNII-QHK6Z47GTG; TB500; Thymosin Beta-4 Analog |
| Molar Mass | 4693 g/mol |
| CAS Number | 77591-33-4 |
| PubChem | 447412051 |
| Total Active Ingredient | 5mg (1 vial) |
| Shelf Life | 36 months |
Drago Pharma Important Notice
FDA Disclaimer: The statements made within this website have not been evaluated by the US Food and Drug Administration. The statements and the products of this company are not intended to diagnose, treat, cure or prevent any disease. All products are for laboratory developmental research USE ONLY. Products are not for human consumption.
Note: These peptides are freeze-dried, a process that not only extends shelf life but also preserves the purity and integrity of the peptides during storage. We do not use any fillers in this process.
There are no reviews yet.